Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
380.50    -26.50 (-6.51%)
Bid:
381.00
Ask:
382.50
Spread: 1.50 (0.394%)
Market Cap: £1.72b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Interim Management Statement

7 Nov 2008 07:00

HgCapital Trust plc - Interim Management Statement 7th November 2008

HgCapital Trust plc ("the Company"), today issues its Interim Management Statement in accordance with FSA Disclosure and Transparency Rule 4.3. This statement relates to the period from 1 July 2008 to 5 November 2008 and incorporates the Company's calculation of its net asset value at 31 October 2008, in the same form as is issued following the end of each month. The Net Asset Value (NAV) at October is based on the valuations of unquoted investments as at 30 June, as set out in the half yearly report issued in August, but is adjusted for realisations, exchange rates, changes in value of quoted securities, and net revenues during the period.

Investment activity during the period

Since the 30 June 2008 the Company has completed the realisation of Addison and sold its quoted shares in Clinphone plc, in addition to completing the realisation of Rolfe and Nolan as described in the half yearly report and accounts. Including deferred proceeds, a total of β€šΒ£23.1 million cash proceeds has been received by the Company. Two acquisitions, of Achilles Group Holdings Limited and King Luxembourg SARL (KVT), have been completed, with the Company investing a total of β€šΒ£10.7 million.

Performance since the 30 June 2008

Since 30 June the total return (NAV plus dividend) was 5.3%, compared with the negative total return of -22.6% of the FTSE All-Share Index. The Company's share price at the end of October was 725.0 pence, a discount of 33.3% against the NAV of 1,086.80 pence. The Company's share price (on a total return basis) fell by 15.4% over the four months to 31 October, in a period when the FTSE All-Share Index and FTSE SmallCap Index declined by 22.6% and 31.6% respectively.

Performance year to date (1 January - 31 October 2008)

The total return (NAV plus dividend) since 1 January was 17.5%, compared with the negative total return of -31.3% of the FTSE All-Share Index. The Company's share price (on a total return basis) decreased by 4.6% over the ten months to 31 October while the FTSE All-Share Index and FTSE SmallCap Index declined by 31.3% and 41.8% respectively.

Current trading

The Company's manager, HgCapital, is represented on the board of every material investment in the portfolio and receives monthly management accounts from all the businesses in which the Company is invested. These are regularly discussed with the Board, together with other information about the strategy and prospects of each business. The latest available trading figures, to the end of September, show some minor slowing in sales growth in a few of the businesses most exposed to a general economic downturn.

Share price and valuation

The discount of the Company's share price against published Net Asset Value has widened, but the discount is lower than that of most other private equity investment trusts. This may reflect the Company's holdings of cash and other liquid assets which, following recent realisations, represent 45.3% of the net assets. The book value of the unquoted portfolio will next be reviewed, as usual, at 31 December in accordance with IPEVCA guidelines.

Investment objective

HgCapital Trust plc gives the investor access to a private equity portfolio run by an experienced and well-resourced Manager that makes investments in fast growing companies over a number of geographies and sectors.

The objective of the Company is to provide shareholders with long-term capital appreciation in excess of the FTSE All-Share Index by investing in unquoted companies. The Company provides investors with exposure to a diversified portfolio of private equity investments primarily in the UK and Continental Europe.

The Company's Benchmark is the FTSE All-Share Index.

Performance

All information is at 31 October 2008 and is unaudited.

Performance at month end with net income reinvested

One Three One year Three Five month months years years Net asset value 3.2% 4.7% 31.1% 100.3% 224.9% Share price -8.3% -15.0% -10.0% 31.8% 198.2% FTSE All-Share Index -11.9% -19.7% -34.4% -9.3% 21.3%

Sources: HgCapital, Capital Economics

ResultsAt 31 October 2008Net asset value:* 1,086.80p Share price: 725.0p Discount 33.3% Total assets: β€šΒ£273.7m Net yield: 3.4% Gearing: Nil% Ordinary shares in issue: 25,186,755 * includes 10 months net revenue of 50.4p.

Unaudited Net Asset Value per Share

The investment portfolio has not been revalued at 31 October 2008. The unaudited Net Asset Value at 31 October is based on the Net Asset Value at 30 June 2008 adjusted to reflect purchases and sales of investments, currency movements and bid values in respect of listed investments. The unaudited Net Asset Value at 31 October 2008 was 1,086.80 pence per share by comparison with 1,032.2 pence at 30 June 2008, an increase of 5.3%. This is after making provision for a carried interest liability of 24.9 pence.

Net revenue for the ten months to 31 October 2008 was 50.4p.

Balance Sheet

At 31 October 2008, the Company's summary balance sheet was as follows:

β€šΒ£m % Unquoted investments 136,340 49.8 ----------- ------ Total investment portfolio 136,340 49.8 Cash/Gilts 123,973 45.3 Other net assets 13,416 4.9 ----------- ------ Net Asset Value 273,729 100.0Investments

Two new investments were completed during the period.

The Company invested β€šΒ£5.2 million in Achilles Group Holdings Limited, a global leader in services for sustainable procurement focusing on buyer-sponsored supplier data management and validation services, with an enterprise value of β€šΒ£ 75 million.

King Luxembourg SARL (KVT), the Swiss fastenings and sealing technology products group, was jointly acquired with Capvis for an enterprise value of β€šΒ£ 260 million. The Company invested β€šΒ£5.5 million.

Realisations

During the period, the Manager completed the sales of Rolfe & Nolan and Addison and sold its quoted shares in Clinphone, returning a total of β€šΒ£23.1 million to the Company, including deferred proceeds. This represents an uplift of over 60.0% of the carrying value as at 30 June 2008.

PortfolioTen Largest InvestmentsCompany Total Assets % Sector VISMA 5.5 TMT Voyage Healthcare 3.2 Healthcare Casa Reha 3.1 Healthcare BMFCO UA t/a Fabory 3.0 Services Atlas t/a Atlas 3.0 Services Interactive Mondo Minerals Co-op 2.9 Industrials Elite 2.8 TMT Sporting Index 2.6 Consumer & Leisure Pulse Staffing 2.5 Services SHL 2.5 Services Total 31.1 Sector Total Assets % TMT 9.9 Industrials 10.0 Consumer & Leisure 8.2 Healthcare 6.5 Services 13.0 Renewable Energy 1.4 Other 0.8 Fixed Interest 45.3 Net current assets 4.9 Total 100.0

This statement is a general description of the financial position and performance of the Company for the period from 1 July 2008 to 31 October 2008. It does not contain any profit forecast or forward looking information. Future performance and share price is likely to be affected by a number of factors, including (but not limited to) general economic and market conditions and specific factors affecting the financial performance or prospects of individual investments within the Company's portfolio.

vendor
Date   Source Headline
4th Aug 20237:15 amRNSEdison issues review on HG Capital Trust (HGT)
20th Jul 20237:00 amRNSHg announces investment in Nomadia
19th Jun 20237:00 amRNSAzets Group secures investment from PAI to join Hg
18th May 20239:00 amRNSHg announces investment in GTreasury
17th May 20235:21 pmRNSResult of AGM
15th May 20237:00 amRNSQ1 2023 Report to 31 March 2023
12th May 20234:53 pmRNSBlock listing Interim Review
4th Apr 202310:04 amRNSDirector/PDMR Shareholding
3rd Apr 20233:51 pmRNSUpdate on HGT's Commitment to Hg's Saturn 3 Fund
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202310:35 amRNSDirector/PDMR Shareholding
28th Mar 202312:24 pmRNSDirector/PDMR Shareholding
16th Mar 20232:14 pmRNSHgCapital Trust results summary with Doceo
15th Mar 202310:55 amRNSDirector/PDMR Shareholding
13th Mar 202310:51 amRNSUpdate on Silicon Valley Bank
13th Mar 20237:00 amRNSAnnual Results & Notice of Annual General Meeting
13th Mar 20237:00 amRNSAnnual Financial Report
31st Jan 20234:50 pmRNSBlock listing Interim Review
13th Dec 20227:00 amRNSHg agrees to sale of Transporeon
16th Nov 20227:00 amRNSEdison issues update on HgCapital Trust (HGT)
14th Nov 20227:00 amRNS3rd Quarter Results
1st Nov 202210:10 amRNSTotal Voting Rights
14th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSIdeagen and ProcessMAP to Combine
4th Oct 20228:25 amRNSTrustQuay Secures Hg Investment
4th Oct 20227:00 amRNSTrustQuay Secures Hg Investment
13th Sep 20227:46 amRNSEdison issues update on HgCapital Trust (HGT)
12th Sep 20227:00 amRNSHgCapital Trust Interim Results 2022
12th Sep 20227:00 amRNSHalf-year Report
2nd Aug 20223:38 pmRNSHolding(s) in Company
20th Jul 20225:50 pmRNSHolding(s) in Company
14th Jul 20221:00 pmRNSHg announces a partial sale of Intelerad
7th Jul 20224:40 pmRNSReplacement: Director/PDMR Shareholding
6th Jul 20227:30 amRNSHg announces further investment in team.blue
5th Jul 20221:43 pmRNSDirector/PDMR Shareholding
4th Jul 20225:18 pmRNSDirector/PDMR Shareholding
28th Jun 20224:00 pmRNSNorstella announces merger agreement with Citeline
24th Jun 20227:00 amRNSHGT Board note agreement on acquisition of Ideagen
14th Jun 20227:00 amRNSHg agrees sale of MEDIFOX DAN to ResMed for US$1bn
9th Jun 20223:56 pmRNSInvestment in TigerRisk Partners
8th Jun 20227:00 amRNSHg further invests in The Access Group
17th May 20226:00 pmRNSHg agrees the sale of itm8 to Axcel
17th May 20227:00 amRNSEdison issues review on HgCapital Trust (HGT)
13th May 20224:54 pmRNSBlock listing Interim Review
10th May 20225:34 pmRNSResult of AGM
9th May 20227:00 amRNS1st Quarter Results
3rd May 20223:23 pmRNSAGM Update - Withdrawal of AGM Resolution
29th Apr 20221:38 pmRNSDirectorate Change
11th Apr 20223:00 pmRNSHg announces investment in LucaNet
1st Apr 20229:45 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.